id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-N-0242-0022,FDA,FDA-2013-N-0242,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Current Good Manufacturing Practices for Positron Emission Tomography Drugs,Notice,30 Day Proposed Information Collection,2022-10-07T04:00:00Z,2022,10,2022-10-07T04:00:00Z,,2022-10-07T16:50:57Z,2022-21842,0,0,09000064853d4562
FDA-2013-N-0242-0016,FDA,FDA-2013-N-0242,"Agency Information Collection Activities; Proposed Collection; Comment Request; Current Good
Manufacturing Practices for Positron Emission Tomography Drugs",Notice,60 Day Proposed Information Collection,2022-04-07T04:00:00Z,2022,4,2022-04-07T04:00:00Z,2022-06-07T03:59:59Z,2022-10-07T16:50:03Z,2022-07392,0,0,0900006484fff3ed